Advertisement

Multiple Sclerosis in an Individual with Intellectual Disability

  • Jarrett Barnhill
Original Article
  • 77 Downloads

Abstract

Multiple sclerosis (MS) is a neurological disorder that affects mostly young adults. Because of the complex mixture of neurological symptoms and cognitive-emotional changes during active phases of the disorder, MS can be confused with several psychiatric disorders. This case study of an individual with a mixed mood disorder, MS and Intellectual and Developmental Disability (IDD) illustrate the complex nature of this problem.

Keywords

Multiple sclerosis Plaques Subcortical dementia Intellectual disability 

References

  1. Adams, R. D., Victor, M., & Ropper, A. H. (1997). Principles of neurology. New York: McGraw-Hill.Google Scholar
  2. Asghar-Ali, A., Taber, K., Hurley, R. A., & Hayman, L. A. (2004). Pure neuropsychiatric presentation of multiple sclerosis. Journal of American Psychiatric Association, 161(2), 226–231.CrossRefGoogle Scholar
  3. Benedict, R. H., Priore, R., Miller, C., Munschauer, F., & Jacobs, L. (2001). Personality disorder in multiple sclerosis with cognitive impairment. Journal of Neuropsychiatry and Clinical Neuroscience, 13(1), 70–76.Google Scholar
  4. Brassington, J. C., & Marsh, N. V. (1998). Neuropsychological aspects of multiple sclerosis. Neuropsychological Reviews, 8, 43–77.CrossRefGoogle Scholar
  5. Comi, G., Filipi, M., Martinelli, V., Campi, A., Rodegher, M., & Alberoni, M. (1995). Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. Journal of Neurological Sciences, 132, 222–227.CrossRefGoogle Scholar
  6. Cummings, J. L. (Ed.). (1990). Subcortical dementia. New York: Oxford University Press.Google Scholar
  7. Denney, D. D., Lynsch, S., Parmenter, B. A., & Horne, N. (2004). Cognitive impairment in relapsing and primary progressive multiple sclerosis: Mostly a matter of speed. Journal of International Neuropsychological Society, 10(7), 948–956.CrossRefGoogle Scholar
  8. Diaz-Olavarreta, C., Cummings, J. L., Velasquez, J., & Garcia de la Cadena, C. (1999). Neuropsychiatric manifestations of multiple sclerosis. The Journal of Neuropsychiatry and Clinical Neurosciences, 11(2), 51–57.Google Scholar
  9. Dooley, J. M., & Wright, B. (1985). Adrenoleukodystrophy mimicking multiple sclerosis. Canadian Journal of Neurological Science, 12(1), 73–74.Google Scholar
  10. Feinstein, A., Feinstein, K., Gray, T., & O’Connor, P. (1997). Prevalence and neurobiological correlates of pathological laughing and crying in multiple sclerosis. Archives Neurology, 54(9), 1116–1121.Google Scholar
  11. Filley, C. M. (2003). White matter disorders. In R. B. Schiffer, & B. S. Fogel (Eds.) Neuropsychiatry: Second edition (pp. 991–1016). Baltimore: Lippincott, Williams, and Wilkins.Google Scholar
  12. Haase, C. G., Tinnefield, M., Maum, I., Ganze, R. E., Haupts, M., & Faustman, P. M. (2004). Cognitive but not mood dysfunction develops in multiple sclerosis during 7-year follow-up. European Journal of Neurology, 52(2), 92–95.CrossRefGoogle Scholar
  13. Heesen, C., Koehler, G., Gross, R., Tessmer, W., Schultz, K. H., & Gold, S. M. (2005). Altered Cytokine responses to cognitive stress in multiple sclerosis patients with fatigue. Multiple Sclerosis, 11(1), 51–57.PubMedCrossRefGoogle Scholar
  14. Kesselring, J., & Klement, U. (2001). Cognitive and affective disturbances in multiple sclerosis. Journal of Neurology, 248, 180–183.PubMedCrossRefGoogle Scholar
  15. Khromov, A., Segal, M., Nissinoff, J., & Fast, A. (2005). Migraines linked to interferon-beta treatment in multiple sclerosis. American Journal of Physical Medical Rehabilitation, 84(9), 644–647.CrossRefGoogle Scholar
  16. Kujali, P., Partin, R., & Ruutiainen, J. (1997). The progress of decline in multiple sclerosis. Brain, 120, 289–297.CrossRefGoogle Scholar
  17. Kumar, A. J., Kohler, W., Kruse, B., Naidu, S., Bergin, A., Edwin, D., et al. (1995). MR Findings in adult-onset adrenoleukodystrophy. American Journal of Neuroradiology, 16(6), 1127–1137.Google Scholar
  18. Madden, K. S., Bellinger, D., & Ackerman, K. (2003). Psychoneuroimmunology interaction between the brain and the immune system. In R. B. Schiffer, & B. S. Fogel (Eds.) Neuropsychiatry: Second edition (pp. 245–271). Baltimore: Lippincott, Williams, Wilkins.Google Scholar
  19. Matthews, P. M., deStefano, N., Narayana, S., Francis, G. S., Wolinsky, J. S., & Antel, J. P. (1998). Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis. Seminars in Neurology, 18, 327–336.PubMedGoogle Scholar
  20. Mc Guinness, M. C., Powers, J., Bias, W. B., Schmeckpaper, B. J., et al. (1997). Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of x-linked adrenoleukodystophy and multiple sclerosis. Journal of Neuroimmunology, 75(1–2), 174–182.CrossRefGoogle Scholar
  21. Metz L. (1998). Multiple sclerosis: Symptomatic therapies. Seminars in Neurology, 18(3), 389–395.Google Scholar
  22. Olek, M. J. (2005). Treatment of progressive multiple sclerosis. UpToDate Online.Google Scholar
  23. O’Riordan, J. I. (1997). Central nervous system white matter diseases other than multiple sclerosis. Current Opinions in Neurology, 10(3), 211–214.CrossRefGoogle Scholar
  24. Ralph, H. B., Bakersmith, R., Simon, J. H., Priore, R., Miller, C., & Munchauser, M. (2002). Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 44–51.Google Scholar
  25. Savettieri, G., Messino, D., Andreoi, V., Catlagirone, C., et al. (2004). Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. Journal of Neurology, 251(10), 1208–1214.PubMedCrossRefGoogle Scholar
  26. Rao SM. (Ed.). (1990). Neurobehavioral aspects of multiple sclerosis. New York: Oxford University Press.Google Scholar
  27. Solaro, C., Uccelli, M., & Mancardi, G. L. (1999). A patient with multiple sclerosis and Down’s syndrome with a rare paroxysmal onset. European Journal of Neurology, 6(4), 505–507.PubMedCrossRefGoogle Scholar
  28. Sorenson, T. L., & Rensohoff, R. (1998). Etiology and pathogenesis of multiple sclerosis. Seminars in Neurology, 18(3), 287–294.Google Scholar
  29. van Reekum, R., Stuss, D., & Ostrander, L. (2005). Apathy: Why care? Journal of Neuropsychiatry and Clinical Neuroscience, 17(1), 7–19.Google Scholar
  30. Weilbach, F. X., & Toyka, K. (2002). Does Down’s syndrome protect against multiple sclerosis? European Neurology, 47(1), 52–55.PubMedCrossRefGoogle Scholar
  31. Weinshenker, G. (1998). The natural history of multiple sclerosis. Seiminars in Neurology, 18(3), 301–308.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Dept of PsychiatryUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations